 | • レポートコード：B-MOR-08391 • 出版社/出版日：Mordor Intelligence / 2018年5月22日 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（受注後2営業日） • 産業分類：Healthcare |
| Single User（1名様用） | ￥629,000 (USD4,250) | ▷ お問い合わせ |
| Team User（7名様用） | ￥666,000 (USD4,500) | ▷ お問い合わせ |
| Corporate User | ￥1,295,000 (USD8,750) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、神経機能代替の世界市場について調べ、神経機能代替の世界規模、市場動向、市場環境、タイプ別（出力神経補綴、入力神経補綴）分析、技術別（脊髄刺激、脳深部刺激、迷走神経刺激、仙骨神経刺激、経頭蓋磁気刺激）分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。 ・イントロダクション ・エグゼクティブサマリー ・神経機能代替の世界市場インサイト ・神経機能代替の世界市場環境 ・神経機能代替の世界市場動向 ・神経機能代替の世界市場規模 ・神経機能代替の世界市場規模：タイプ別（出力神経補綴、入力神経補綴） ・神経機能代替の世界市場規模：技術別（脊髄刺激、脳深部刺激、迷走神経刺激、仙骨神経刺激、経頭蓋磁気刺激） ・神経機能代替の世界市場：地域別市場規模・分析 ・神経機能代替の北米市場規模・予測 ・神経機能代替のアメリカ市場規模・予測 ・神経機能代替のヨーロッパ市場規模・予測 ・神経機能代替のアジア市場規模・予測 ・神経機能代替のインド市場規模・予測 ・神経機能代替の韓国市場規模・予測 ・関連企業情報・競争状況 |
The global neuroprosthetics market is expected to grow at a CAGR of 12.4% over the forecast period, 2018-2023. Neuroprosthetics is a branch of neuroscience and biomedical engineering concerned with developing neural prostheses. Neural prostheses are an array of devices that can substitute for the functions of a motor, sensory, or cognitive modality that may have been damaged because of an injury or a disease.
Increasing Incidence of Hearing Loss
It is expected that by 2020, more than 44 million American adults aged 20 or older are expected to suffer from hearing loss. Due to increasingly aging sections of the population, this number is projected to reach 73.5 million by 2060. The total population with hearing disorders in the United States will, therefore, increase from about 15% of adults to 22%. Research has also forecasted higher rates of hearing loss, partly due to the increasing exposure to loud sounds played through headphones and ear buds. Furthermore, other means of exposure to loud sounds in busy cities or around loud machinery may lead to a higher rate of hearing loss. Cochlear implant is the oldest form of neuroprosthetic, which was approved for use by the U.S. Food and Drug Administration (FDA) in 1984. This device proves to be beneficial for people with deafness or severely hard-of-hearing. This device can also be used by patients who have experienced intense hearing loss caused by disease or injury, allowing them to hear sounds in their environment. Scientists continue to work on the technology of the external machinery and the design and positioning of the internal electrode to improve performance and provide more naturalistic sound. This will help drive the market in the forecast years. Along with this, other factors, such as the increasing number of patients suffering from neurological disorders and nerve injury and increasing cases of amputation due to the rising number of accidents & injuries will further drive the market in the future.
High Cost of Neuroprosthetics and Unfavorable Reimbursement Scenario
Neuroprosthetics is a relatively new and constantly evolving treatment option for the treatment of hearing damage, making them a very expensive treatment option for most of the users. Neuroprosthetics such as cochlear prosthesis, visual prosthesis, and hippocampal (or cognition) prostheses are generally very expensive and make it difficult for most of the patients to access. This, along with other factors such as availability of alternative treatment options and lack of trained professionals, will lead to the slowdown of this market in the forecast period.
North America to Maintain Lead in the Market
The market is dominated by North America, followed by Europe. However, the APAC region is expected to witness the highest growth rate during the forecast period. The presence of emerging economies like China and India, large population, increasing funding and support for the launches of new products, and increasing neurological disorders in the region are some of the key factors driving the high growth of this regional segment.
Key Developments in the Market:
• November 2017 – The U.S. Food and Drug Administration approved a remote feature for follow-up programming sessions for the Nucleus Cochlear Implant System through a telemedicine platform. The remote programming feature is indicated for patients who have had six months of experience with their cochlear implant sound processor and are comfortable with the programming process.
• November 2017 – Researchers report amputees are able to control a robotic arm with help of brain implants and BMI technology. The study details how brain areas that control both the intact arm and amputated limb can create new connections and learn to control the robotic arm.
Major Players: ABBOTT, BOSTON SCIENTIFIC, COCHLEAR, LIVANOVA, MED-EL, MEDTRONIC, NDI MEDICAL, NEUROPACE, NEVRO, RETINA IMPLANT, SECOND SIGHT, AND SONOVA, amongst others.
Reasons to Purchase the Report
• Current and future neuroprosthetics market in the developed and emerging markets
• Analysis of various perspectives of the market with the help of Porter’s five forces analysis
• The segment that is expected to dominate the market
• Regions that are expected to witness the fastest growth during the forecast period
• Identify the latest developments, market shares, and strategies employed by the major market players
• 3 month analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report
• This report can be customized to meet your requirements. Please connect with our representative, who will ensure you to get a report that suits your needs.
レポート目次1. Introduction
1.1 Market Definition
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
5.1 Current Market Scenario
5.2 Porter’s Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threat of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Increasing Number of Patients Suffering From Neurological Disorders and Nerve Injury
6.1.2 Increasing Incidence of Hearing Loss
6.1.3 Increasing Cases of Amputation Due to the Rising Number of Accidents & Injuries
6.2 Market Restraints
6.2.1 Availability of Alternative Treatment Options
6.2.2 High Cost of Neuroprosthetics and Unfavorable Reimbursement Scenario
6.2.3 Lack of Trained Professionals
6.3 Opportunities
6.4 Key Challenges
7. Market Segmentation
7.1 By Type
7.1.1 Output Neural Prosthetics
7.1.1.1 Motor Prosthetics
7.1.1.2 Cognitive Prosthetics
7.1.2 Input Neural Prosthetics
7.1.2.1 Cochlear Implants
7.1.2.2 Bionic Eye/Retinal Implants
7.2 By Technique
7.2.1 Spinal Cord Stimulation
7.2.2 Deep Brain Stimulation
7.2.3 Vagus Nerve Stimulation
7.2.4 Sacral Nerve Stimulation
7.2.5 Transcranial Magnetic Stimulation
7.3 By Application
7.3.1 Motor Neuron Disorders
7.3.1.1 Parkinson’s Disease
7.3.1.2 Epilepsy
7.3.2 Physiological Disorders
7.3.2.1 Auditory Processing Disorders
7.3.2.2 Ophthalmic Disorders
7.3.2.3 Cardiovascular Disorders
7.3.2.4 Urology Disorders
7.3.3 Cognitive Disorders
7.3.3.1 Alzheimer’s Disease
7.3.3.2 Paralysis
7.4 By Geography
7.4.1 North America
7.4.1.1 United States
7.4.1.2 Canada
7.4.1.3 Mexico
7.4.2 Europe
7.4.2.1 France
7.4.2.2 Germany
7.4.2.3 United Kingdom
7.4.2.4 Italy
7.4.2.5 Spain
7.4.2.6 Rest of Europe
7.4.3 Asia-Pacific
7.4.3.1 India
7.4.3.2 Australia & New Zealand
7.4.3.3 South Korea
7.4.3.4 Others
7.4.4 Rest of the World
7.4.4.1 Saudi Arabia
7.4.4.2 Brazil
7.4.4.3 Others
8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches
9. Key Players
9.1 Abbott
9.2 Boston Scientific
9.3 Cochlear
9.4 Livanova
9.5 Med-El
9.6 Medtronic
9.7 NDI Medical
9.8 Neuropace
9.9 Nevro
9.10 Retina Implant
9.11 Second Sight
9.12 Sonova
*List Not Exhaustive
10. Future of the Market